Elisabeth Vodicka

1.8k total citations · 1 hit paper
32 papers, 1.2k citations indexed

About

Elisabeth Vodicka is a scholar working on Epidemiology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elisabeth Vodicka has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elisabeth Vodicka's work include Cervical Cancer and HPV Research (10 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (7 papers). Elisabeth Vodicka is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (7 papers). Elisabeth Vodicka collaborates with scholars based in United States, United Kingdom and Kenya. Elisabeth Vodicka's co-authors include Jan Walker, James D. Ralston, Jonathan Darer, Suzanne G. Leveille, Tom Delbanco, Joann G. Elmore, Stephen E. Ross, Henry J. Feldman, Long Ngo and Roanne Mejilla and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Elisabeth Vodicka

31 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inviting Patients to Read Their Doctors' Notes: A Quasi-experimental Study and a Look Ahead

2012 491 citations Tom Delbanco, Jan Walker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabeth Vodicka United States	14	538	381	293	281	204	32	1.2k
Lipika Samal United States	24	587 1.1×	413 1.1×	353 1.2×	174 0.6×	177 0.9×	76	1.6k
Theresa Cullen United States	15	423 0.8×	244 0.6×	187 0.6×	83 0.3×	173 0.8×	49	1.1k
Mita Sanghavi Goel United States	15	801 1.5×	286 0.8×	465 1.6×	138 0.5×	212 1.0×	30	1.8k
Diane Hauser United States	16	497 0.9×	401 1.1×	277 0.9×	145 0.5×	116 0.6×	27	1.2k
Neha Trivedi United States	17	452 0.8×	259 0.7×	288 1.0×	183 0.7×	79 0.4×	35	1.1k
Naleef Fareed United States	17	563 1.0×	183 0.5×	240 0.8×	76 0.3×	101 0.5×	64	1.0k
Sidna M. Tulledge‐Scheitel United States	20	418 0.8×	144 0.4×	223 0.8×	168 0.6×	82 0.4×	43	1.1k
Andrew J. Sussman United States	11	655 1.2×	456 1.2×	467 1.6×	445 1.6×	70 0.3×	19	1.4k
Robert M. Cronin United States	22	442 0.8×	238 0.6×	197 0.7×	103 0.4×	137 0.7×	67	1.4k
Natalia V. Oster United States	18	405 0.8×	252 0.7×	188 0.6×	169 0.6×	204 1.0×	35	942

Countries citing papers authored by Elisabeth Vodicka

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Vodicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Vodicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Vodicka more than expected).

Fields of papers citing papers by Elisabeth Vodicka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Vodicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Vodicka. The network helps show where Elisabeth Vodicka may publish in the future.

Co-authorship network of co-authors of Elisabeth Vodicka

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Vodicka. A scholar is included among the top collaborators of Elisabeth Vodicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Vodicka. Elisabeth Vodicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pecenka, Clint, Andrea Rodríguez, Carlos Rojas‐Roque, et al.. (2024). Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis. SHILAP Revista de lepidopterología. 2(1). e000975–e000975.

Nyiro, Joyce U., Bryan O. Nyawanda, Martin Mutunga, et al.. (2024). The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya. BMC Public Health. 24(1). 2410–2410. 3 indexed citations

Mvundura, Mercy, et al.. (2024). Cervical cancer screening and treatment costing in Senegal. Pan African Medical Journal. 47. 151–151. 2 indexed citations

Bhat, Niranjan, Elisabeth Vodicka, Ashish Bavdekar, et al.. (2024). The evidence base for rotavirus vaccination in India: Current status, future needs. Vaccine. 44. 126551–126551. 2 indexed citations

Nyawanda, Bryan O., Joyce U. Nyiro, Elisabeth Vodicka, et al.. (2023). Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021. Vaccines. 11(6). 1055–1055. 4 indexed citations

Nyawanda, Bryan O., Nickson Murunga, Nancy A. Otieno, et al.. (2023). Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010–2018. BMC Medicine. 21(1). 122–122. 11 indexed citations

Ha, Lien Anh, et al.. (2023). Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study. BMC Infectious Diseases. 23(1). 73–73. 8 indexed citations

Llave, Cecilia, et al.. (2022). The cost-effectiveness of human papillomavirus vaccination in the Philippines. Vaccine. 40(27). 3802–3811. 16 indexed citations

Vodicka, Elisabeth, et al.. (2022). The potential cost-effectiveness of HPV vaccination among girls in Mongolia. Vaccine X. 11. 100161–100161. 3 indexed citations

10.

Kosen, Soewarta, et al.. (2022). Expanding japanese encephalitis vaccination to selected endemic indonesia provinces: A cost-effectiveness analysis. Vaccine X. 11. 100179–100179. 3 indexed citations

11.

Vodicka, Elisabeth, et al.. (2021). The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana. Vaccine. 40. A85–A93. 16 indexed citations

12.

Mvundura, Mercy, et al.. (2020). Assessing the incremental costs and savings of introducing electronic immunization registries and stock management systems: evidence from the better immunization data initiative in Tanzania and Zambia. Pan African Medical Journal. 35(Supp 1). 11–11. 6 indexed citations

13.

Anwari, Palwasha, Frédéric Debellut, Elisabeth Vodicka, et al.. (2019). Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan. Vaccine. 38(6). 1352–1362. 16 indexed citations

14.

Vodicka, Elisabeth, Michael H. Chung, Marita Zimmermann, et al.. (2019). Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya. PLoS ONE. 14(6). e0217331–e0217331. 14 indexed citations

15.

Mercieca‐Bebber, Rebecca, Jessica Roydhouse, Lucy Busija, et al.. (2018). Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Quality of Life Research. 27(10). 2581–2591. 31 indexed citations

16.

Campos, Nicole G., Mercy Mvundura, José Jerónimo, et al.. (2017). Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open. 7(6). e015048–e015048. 26 indexed citations

17.

Vodicka, Elisabeth, et al.. (2017). Point-of-Care Testing for Anemia, Diabetes, and Hypertension: A Pharmacy-Based Model in Lima, Peru. Annals of Global Health. 83(2). 394–394. 13 indexed citations

18.

Vodicka, Elisabeth, K. Kim, Emily Beth Devine, et al.. (2015). Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007–2013). Contemporary Clinical Trials. 43. 1–9. 160 indexed citations

19.

Vodicka, Elisabeth, K. Kim, Beth Devine, et al.. (2015). Inclusion of Patient-Reported Outcome Measures In Registered Clinical Trials: Evidence From Clinicaltrials.Gov (2007-2013). Value in Health. 18(3). A209–A210. 84 indexed citations

20.

Vodicka, Elisabeth, Roanne Mejilla, Suzanne G. Leveille, et al.. (2013). Online Access to Doctors' Notes: Patient Concerns About Privacy. Journal of Medical Internet Research. 15(9). e208–e208. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact